Short Interest in Heart Test Laboratories, Inc. (NASDAQ:HSCS) Rises By 32.0%

Heart Test Laboratories, Inc. (NASDAQ:HSCS) saw a large growth in short interest in November. As of November 15th, there was short interest totalling 30,500 shares, a growth of 32.0% from the October 31st total of 23,100 shares. Currently, 3.7% of the shares of the company are sold short. Based on an average daily volume of 356,800 shares, the short-interest ratio is currently 0.1 days.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets reiterated a “buy” rating and set a $15.00 price objective on shares of Heart Test Laboratories in a research note on Monday, September 23rd.

Heart Test Laboratories Stock Performance

Heart Test Laboratories stock traded up $0.05 during trading hours on Friday, hitting $2.95. 10,912 shares of the stock traded hands, compared to its average volume of 135,732. Heart Test Laboratories has a 1 year low of $2.36 and a 1 year high of $25.09. The stock has a market capitalization of $2.69 million, a price-to-earnings ratio of -0.14 and a beta of 3.27. The company has a debt-to-equity ratio of 0.08, a current ratio of 4.49 and a quick ratio of 4.02. The firm’s 50 day moving average price is $3.38 and its 200-day moving average price is $4.08.

Heart Test Laboratories (NASDAQ:HSCS) last issued its earnings results on Thursday, September 12th. The company reported ($2.64) EPS for the quarter. As a group, equities analysts expect that Heart Test Laboratories will post -9.82 EPS for the current fiscal year.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.